So far it worked very well: They could hide Triple Relenza Production, Lani Phase 3 Results and 20 million cashback !
Result: Shareprice didn´t move !
Shareprice of ALL flu-stocks on Nasdaq would have EXPLODED by +500% with news like this.
It´s incredible...
Look at Biocryst, they have positive Phase 3 results for IV Peramivir, which imho has not the marketing-potential that Lani has. Their sp went up 300% after positive Phase 3 results.
Biota sp went up 5% after Lani-results...
It´s sad and we´re very frustrated, since imho this is PURE shareprice-manipulation.
Imho the reason for the sp-manipulation is a planned takeover on a low price-level.
Regards from Germany
Eric
BTA Price at posting:
$1.99 Sentiment: Hold Disclosure: Held